...
首页> 外文期刊>Vaccine >Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students
【24h】

Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students

机译:兽医对学生进行狂犬病前狂犬病疫苗接种后抗体效价不足的发生率和变量

获取原文
获取原文并翻译 | 示例
           

摘要

Background: This study sought to determine the proportion of subjects with inadequate antibody titers at two years after pre-exposure rabies vaccination and identify variables associated with inadequate antibody titers. Methods: A retrospective chart review of vaccination records of veterinary students in Michigan, 2004-2009, was conducted. Antibody titers <0.5 IU/ml as estimated by rapid fluorescent focus inhibition test were classified as inadequate. Variables were compared between the two groups to identify factors associated with inadequate titers at two years. Results: A total of 603 subjects (mean age 24.1 +/- 4.2 years, male:female 106:497) were included. Nearly one third (177/603, 29.4%) had inadequate titers at two years. Male gender (adjusted odds ratio (AOR) 1.87, 1.07-3.27; p = 0.029), vaccine manufacturer (AOR 1.49, 1.16-1.92; p = 0.002), BMI >25 (AOR 1.61, 1.02-2.54; p = 0.043), and duration between first and third doses of vaccine >21 days (AOR 2.49, 1.26-4.97; p = 0.009) were independently associated with inadequate titers. Conclusions: Twenty-nine percent of subjects had inadequate antibody titers against rabies at 2 years. Gender, vaccine type/manufacturer, BMI of 25 or greater, and more than 21 days between the first and third doses of vaccine were independently associated with inadequate antibody titers at two years. Our data would support modifying the recommendations, so the third dose is recommended at 21 days rather than 21-28 days
机译:背景:这项研究试图确定暴露前狂犬病疫苗接种后两年抗体滴度不足受试者的比例,并确定与抗体滴度不足相关的变量。方法:对密歇根州2004-2009年兽医学生的疫苗接种记录进行回顾性图表审查。通过快速荧光聚焦抑制试验估计的抗体滴度<0.5 IU / ml被归类为不足。比较两组之间的变量,以确定与两年滴度不足有关的因素。结果:共纳入603名受试者(平均年龄24.1 +/- 4.2岁,男性:女性106:497)。近两年有近三分之一(177/603,29.4%)的滴度不足。男性(调整比值比(AOR)1.87,1.07-3.27; p = 0.029),疫苗生产商(AOR 1.49,1.16-1.92; p = 0.002),BMI> 25(AOR 1.61,1.02-2.54; p = 0.043) ,以及第一剂和第三剂疫苗之间> 21天的持续时间(AOR 2.49,1.26-4.97; p = 0.009)与滴度不足相关。结论:2%的受试者在2年时对狂犬病的抗体滴度不足。性别,疫苗类型/制造商,BMI为25或更大以及在第一和第三剂疫苗之间间隔21天以上与两年中抗体效价不足相关。我们的数据将支持修改建议,因此建议在21天而不是21-28天服用第三剂

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号